Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Kuwait launches probe into espionage, state security cases
Trump, Iran threaten to escalate conflict with attacks on energy and water facilities
Israeli airstrikes kill four in Gaza, Palestinian officials say
Iran says Hormuz open to all but ‘enemy-linked’ ships
GCC renews condemnation of ongoing Iranian attacks
Seven killed in Qatar helicopter crash due to technical malfunction
Four killed as severe weather hits Oman, search continues for missing person
Japan could consider Hormuz minesweeping if ceasefire reached, minister says
